Abstract
SARS-CoV-2 has been detected in more than 141 million people and caused more than 3 million deaths worldwide. To reduce the additional loss of millions of lives until natural immunity is reached, researchers have focused on the only known method to stop the COVID-19 pandemic: vaccines. The pandemic has propelled high-speed vaccine development, some based on novel technology previously not utilized in the vaccine field. The new technology opens new possibilities and comes with challenges because the long-term performance of the new platforms is unknown. Here we review the current leading vaccine candidates against COVID-19 and outline the advantages and disadvantages as well as the unknowns of each candidate.
【초록키워드】 COVID-19, SARS-CoV-2, Vaccine development, pandemic, Vaccines, COVID-19 pandemic, death, vaccine candidate, platform, Disadvantages, natural immunity, disadvantage, researcher, caused, reached, reduce, the vaccine, 【제목키워드】 SARS-CoV-2 vaccine, Research,